Immunohistochemical diagnostic procedures reveal that 60% of patients have slight expression of CD34 (vascular origin), 21% have spinal muscular atrophy (epithelial and/or glandular origin), and 8% reveal desmin (muscular origin) [3]. This evidence concerns the gene DES and proximal spinal muscular atrophy.